standard-title
Alzheimer’s Disease
Latest News Regarding Alzheimer’s Disease and Your Health
Loading…
Research has linked a particular sleep disorder called rapid eye movement (REM) sleep behavior disorder with a diagnosis of Parkinson’s disease. What characterizes this sleep problem, and can its presence be a good way to predict Parkinson’s risk? People who experience a sleep disorder that causes them to act out their dreams have a high risk of developing Parkinson’s disease. Data from the National Institutes of Health (NIH) indicate that every year, approximately 50,000 people in the United States learn that they have Parkinson’s disease, a neurological condition that affects a person’s motor function and exposes them to other neurodegenerative problems, such as Alzheimer’s disease. Researchers still do not fully understand exactly what causes Parkinson’s disease, but they have identified a few risk factors that can predispose a person to develop this condition. These include a person’s age and sex as well as some genetic factors. Still, it remains a challenge to establish early on who is likely to develop Parkinson’s disease at some point in their life. However, a team of researchers from McGill University in Montreal, Canada decided to see if one particular factor — a sleep disorder called REM sleep behavior disorder (RBD) — could be a […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News THURSDAY, June 27, 2019 (HealthDay News) — Every college student misplaces keys or forgets an appointment from time to time. Usually it’s no big deal. But a new study warns that when young people with a family history of Alzheimer’s disease have memory lapses, it could be an early sign of something serious. That’s the concern raised by a new memory test taken by nearly 60,000 men and women between the ages of 18 and 85. The results revealed that participants between 18 and 65 who had family members with Alzheimer’s scored lower than those who did not. That included even young adults in their 20s. But, “no one should feel doomed to experience Alzheimer’s, certainly not simply because your parents or grandparents were diagnosed with the disease,” stressed study author Matt Huentelman. He is a professor of neurogenomics with TGen, a genetics research institute based in Phoenix. Lots of non-inherited factors play a role in Alzheimer’s risk, he explained. And, “there are many cases of people with family history and/or high genetic risk for Alzheimer’s who live long lives without memory problems.” But there’s no getting around the fact that roughly 75% […]
Extreme daytime sleepiness is often a top symptom of Alzheimer’s disease but what, exactly, causes it? New research finally brings us an answer. A specific type of protein may cause daytime sleepiness in people with Alzheimer’s, according to a recent study. Many people with Alzheimer’s disease have a tendency to sleep a lot during the day, even when they have had a full night’s sleep. Based on links between excessive sleepiness and neurodegenerative conditions, researchers are speculating that looking at daytime napping patterns could help predict the development of Alzheimer’s. But what remains unclear is why, exactly, people with this condition experience the need to sleep so often. A new study, conducted by researchers at the University of California, San Francisco (UCSF) and other institutions, shows that people with Alzheimer’s disease experience major brain cell loss in regions of the brain tasked with keeping us awake. The findings, which appear in the journal Alzheimer’s & Dementia, also suggest that an overaccumulation of tau protein triggers these brain changes. In Alzheimer’s disease, tau proteins form tangles that disrupt communication between neurons (brain cells) and impact cell health. “Our work shows definitive evidence that the brain areas promoting wakefulness degenerate due to […]
Dehydration can cause headaches and several physiological issues, and older adults are most at risk of experiencing it. Does it also affect cognitive function, however? And might overhydration also affect mental performance? Share on PinterestRecent research set out to reveal whether or not hydration levels can affect cognitive performance in older adults. Dehydration can cause headaches, lethargy, dizziness, and many other issues, depending on how severe it is. Studies have tended to focus on the effects of dehydration in younger populations — especially in the context of sports and fitness, where overexertion and abundant sweating can cause people to lose more fluids than they than ingest. However, one segment of the population is particularly susceptible to dehydration: older adults. “As we age, our water reserves decline due to reductions in muscle mass, our kidneys become less effective at retaining water, and hormonal signals that trigger thirst and motivate water intake become blunted,” explains Hilary Bethancourt, Ph.D., from the Pennsylvania State University College of Health and Human Development in State College. Older adults also have a higher risk of cognitive impairment. Are their hydration levels and their cognitive performance linked in any way? Bethancourt and colleagues set out to answer this […]
New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. This knowledge, however, also indicates a potential preventive strategy, researchers show. An irregular heartbeat speeds up the rate at which cognitive function deteriorates, but there may be an easy way to address this. In a new study paper published yesterday in the journal Neurology, researchers at the Karolinska Institute and Stockholm University, which are in Sweden, explain that atrial fibrillation (A-fib) is linked with an increased risk of developing dementia. In A-fib, the heart’s atria — or the chambers that receive blood and then send it to the ventricles, which pump it out to the rest of the body — beat irregularly. Because of this, blood can pool inside the heart and form clots, which may later circulate to the brain, leading to a stroke. The new study has found that A-fib also increases the risk of another health problem as people age — namely, dementia. However, this warning also comes with an encouraging solution, the authors explain. “Compromised blood flow caused by atrial fibrillation may affect the brain in a number of ways,” as study co-author Chengxuan […]
By Rich HolmesHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Nov. 6, 2019 (HealthDay News) — Just 10 minutes of exercise a day appears to sharpen mental prowess, new research suggests. “Getting off the couch and walking a block can help keep you on the right track,” said study author Nicole Spartano, a research assistant professor at Boston University School of Medicine. Her team looked 2,770 participants in the Framingham Heart Study who were divided into two groups: middle-aged and older. The Framingham study has followed the health and habits of its original participants from Massachusetts and their descendants since 1948. The researchers found that roughly 10 to 20 minutes of moderate to vigorous activity a day was associated with better brain function for both groups. For the middle-age group, just 10 minutes of moderate to vigorous activity was linked to better verbal memory. For the older group, the total amount of activity — not the intensity — corresponded to stronger mental skills. While the study only found associations, Spartano said the findings were especially significant for older people, who may find it difficult or impossible to meet the exercise guidelines set by the U.S. Department of Health and Human Services. Those […]
Latest Alzheimer’s News THURSDAY, Dec. 5, 2019 (HealthDay News) — Imagine a blood test that could spot whether you are aging too quickly. New research suggests it’s not the stuff of science fiction anymore. The scientists analyzed plasma — the cell-free, fluid part of blood — from more than 4,200 people between the ages of 18 and 95, and found a link between 373 proteins and aging. “We’ve known for a long time that measuring certain proteins in the blood can give you information about a person’s health status — lipoproteins for cardiovascular health, for example,” said study senior author Tony Wyss-Coray. He’s co-director of the Alzheimer’s Disease Research Center at Stanford University in California. “But it hasn’t been appreciated that so many different proteins’ levels — roughly a third of all the ones we looked at — change markedly with advancing age,” he added in a university news release. The study was published Dec. 5 in the journal Nature Medicine. “Proteins are the workhorses of the body’s constituent cells, and when their relative levels undergo substantial changes, it means you’ve changed, too,” Wyss-Coray explained. “Looking at thousands of them in plasma gives you a snapshot of what’s going on […]
One hallmark of Alzheimer’s disease is the massing of tangles of tau protein in the brain. Now, a new study in mice proposes that a type of brain immune cell called microglia drives the tissue damage that is linked to tau clumping. Could deactivating microglia be the key to treating Alzheimer’s disease? Brain scans of people with Alzheimer’s disease have revealed that the brain damage that accompanies forgetfulness and confusion becomes visible soon after tau tangles start fusing into a mass. A recent Journal of Experimental Medicine paper explains how the microglia become active as the tau clumps begin to form. The study authors also showed that eliminating microglia greatly reduced tau-related damage in the brains of mice genetically modified to develop protein tangles. They suggest that the findings point to a new way to delay the dementia that tau-related brain damage causes in humans. “If you could target microglia in some specific way and prevent them from causing damage,” says senior study author David M. Holtzman, a professor of neurology at the Washington University School of Medicine in St. Louis, MO, “I think that would be a really important, strategic, novel way to develop a treatment.” Toxic protein and […]
Dementia is a term that describes a variety of symptoms affecting a person’s cognitive functioning, including their ability to think, remember, and reason. It tends to get worse over time, so there are a few key early warning signs. Dementia occurs when nerve cells in a person’s brain stop working. Although it typically happens in older people, it is not an inevitable part of aging. The brain’s natural deterioration happens to everyone as they grow older, but it occurs more quickly in people with dementia. There are many different types of dementia. According to the National Institute on Aging, the most common is Alzheimer’s disease. Other types include: Lewy body dementia frontotemporal dementia vascular disorders mixed dementia, or a combination of types There are 10 typical early signs of dementia. For a person to receive a diagnosis, they would usually experience two or more of these symptoms, and the symptoms would be severe enough to interfere with their daily life. These early signs of dementia are: 1. Memory loss A person developing dementia may have trouble remembering dates or events. Memory loss is a common symptom of dementia. A person with dementia may find it difficult to recall information they […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News MONDAY, Nov. 18, 2019 (HealthDay News) — Concerns that cholesterol-lowering statin drugs can impair brain health appear to be unfounded, according to new research. “Statins won’t make you stupid or cause memory loss,” said lead researcher Dr. Katherine Samaras, a professor of medicine at St. Vincent’s Clinical School of Medicine in Darlinghurst, Australia. And for some people at risk of dementia, statins like Lipitor (atorvastatin) and Crestor (rosuvastatin) may improve memory and mental functioning, her team found. Many millions of people take statins because of heart disease or high cholesterol. But reports that the drugs could cause memory loss led the U.S. Food and Drug Administration in 2012 to require a black box warning on all statin medications, she said. However, “we could find no overall impact on memory or any other aspect of cognitive function over six years in a large population of older people, who had extensive testing every two years,” Samaras said. The observational nature of this study means the research can’t be considered conclusive, only that a strong link exists, the researchers noted. “Any person who takes statins and is concerned about their memory and cognition should discuss this […]
New research suggests that vital exhaustion, a marker of psychological distress, may raise the risk of developing Alzheimer’s disease. Psychological distress in midlife may bring about dementia later on, suggests new research. Many factors may increase Alzheimer’s risk, including age, family history, and genetic makeup. Certain health issues, such as cardiovascular disease or diabetes, may also influence the odds of experiencing dementia because they impact the blood vessels. New research indicates that psychological factors could also affect risk. Psychological distress, in particular, may increase the likelihood of developing dementia, suggests the new study. Specifically, researchers led by Sabrina Islamoska, a doctoral candidate in the Department of Public Health at the University of Copenhagen, Denmark, set out to investigate the possibility of a link between vital exhaustion and Alzheimer’s disease. Vital exhaustion describes “a mental state of psychological distress” that manifests as irritability, fatigue, and a feeling of demoralization. As the researchers explain, vital exhaustion may be a reaction to “unsolvable problems” in one’s life, especially when the person has been exposed to stressors for a prolonged period. So, vital exhaustion can be seen as a sign of psychological distress. Previous studies have noted that vital exhaustion may raise the risk […]
Alzheimer’s is a relentless disease in which toxic clusters of beta-amyloid protein collect in brain cells. Now, scientists have designed a synthetic peptide, or small protein, that can block beta-amyloid in its early and most harmful stages. New research may have found a way to stop Alzheimer’s-related brain damage in its early stages. The synthetic peptide, which has only 23 amino acids, folds into structures called alpha sheets. The sheets bind to early-stage, small clumps of beta-amyloid and stop them forming larger masses. A team from the University of Washington (UW) in Seattle and other research centers in the United States designed and produced the synthetic peptide and also tested it in cells and animals. The tests showed that alpha sheets of the peptide reduced the toxic impact of beta-amyloid in cultured human brain cells. The sheets also blocked early forms of beta-amyloid in animal models of Alzheimer’s disease. The Proceedings of the National Academy of Sciences is shortly to feature a paper about the study. The researchers say that the findings could lead to treatments that clear away toxic beta-amyloid in its early forms. They also see potential for using the peptide as the basis of a test for […]
Latest Alzheimer’s News By Amy NortonHealthDay Reporter WEDNESDAY, Jan. 29, 2020 (HealthDay News) — Older adults who regularly consume a group of antioxidants called flavonols may have a decreased risk of developing Alzheimer’s disease, a new study suggests. The compounds exist in many fruits and vegetables, with the richest sources including green vegetables like kale, spinach and broccoli, apples and tea. The researchers found that of over 900 older adults they followed for six years, the one-fifth with the highest flavonol intake were 48% less likely to develop Alzheimer’s than the one-fifth with the lowest intake. The findings do not prove the antioxidants are a magic bullet against dementia, the researchers stressed. But they add to evidence that a healthy diet — including plenty of fruits and vegetables — may help protect the aging brain. While studies have linked healthy eating habits to a lower risk of mental decline, the new findings get closer to one potential reason, according to lead researcher Dr. Thomas Holland. “We’ve understood that fruits and vegetables are great for our health. We wanted to focus more on the ‘why,’” said Holland, of Rush University in Chicago. Flavonols are known to act as antioxidants and fight […]
Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — Rates of Alzheimer’s disease are higher in women than in men, and researchers now think they know why. A team from Vanderbilt University Medical Center, in Nashville, Tenn., has identified gender differences in how the Alzheimer’s-related protein tau spreads in the brain. Research suggests that tau spreads through the brain like an infection, moving from neuron to neuron and turning other proteins into abnormal tangles that result in the death of brain cells. In this study, investigators used data from positron emission tomography (PET) scans of healthy people and patients with mild mental (cognitive) impairment to create a graph analysis of how tau spreads. “It’s kind of like reconstructing a crime scene after a crime. You weren’t there when it happened, but you can determine where an intruder entered a house and what room they entered next,” said lead investigator Sepi Shokouhi, an assistant professor of psychiatry and behavioral sciences. “The graph analysis does something similar to show how tau spreads from one region to another,” Shokouhi explained in a center news release. The researchers found that the structure of tau networks is different in men and women, with women […]
Researchers from the Massachusetts Institute of Technology have developed a machine-learning model that could predict the rate of Alzheimer’s-related cognitive decline for up to 2 years in the future. MIT researchers have developed a machine-learning model that they say could accurately predict cognitive decline. Alzheimer’s disease affects millions of people worldwide, yet scientists still do not know what causes it. For this reason, prevention strategies can be hit and miss. Moreover, healthcare professionals have no clear way of determining a person’s rate of cognitive decline once a doctor has diagnosed them with Alzheimer’s. Now, researchers from the Massachusetts Institute of Technology (MIT) in Cambridge — in collaboration with specialists from other institutions — have developed a machine-learning model that could allow specialists to predict how much a person’s cognitive functioning will change up to 2 years in advance of this decline becoming established. The team — made of Ognjen Rudovic, Yuria Utsumi, Kelly Peterson, Ricardo Guerrero, Daniel Rueckert, and Prof. Rosalind Picard — will present their project later this week at the Machine Learning for Healthcare conference. This year’s conference will take place in Ann Arbor, MI. “Accurate prediction of cognitive decline from 6 to 24 months is critical to […]
A common class of drugs that doctors prescribe for a number of conditions — from bladder problems to Parkinson’s disease and depression — may increase a person’s risk of dementia, a large new study concludes. Some common drugs may increase dementia risk. New research by scientists from the University of Nottingham in the United Kingdom has analyzed the link between a certain class of drugs and the risk of dementia. The drugs in question, called anticholinergics, work by inhibiting a chemical messenger called acetylcholine. Their effect is to help relax or contract muscles, and doctors can prescribe them to help treat bladder conditions, gastrointestinal problems, and some of the symptoms of Parkinson’s disease. In their new study, which looked at data from tens of thousands of participants, the researchers concluded that anticholinergics may increase a person’s risk of developing dementia. The National Institute for Health Research funded this study, and the scientists published their findings yesterday in JAMA Internal Medicine. An almost 50% increase in risk For their study, lead researcher Prof. Carol Coupland and team analyzed the medical records of 58,769 people with dementia and 225,574 people without dementia. They were all 55 years old or above at baseline. […]
(HealthDay News) — It’s taking you longer than it once did to learn a new task. Or you’ve forgotten about today’s doctor’s appointment. Should you be worried? Latest Alzheimer’s News In other words, do you have mild forgetfulness or symptoms of a more serious memory problem? The National Institute on Aging says you should speak to your doctor, who can help determine if your memory and thinking problems are normal or not, and what might be causing them. Signs of a more serious memory issue include: Asking the same questions repeatedly. Getting lost in familiar places. Not being able to follow instructions. Becoming confused about time, people or places. Copyright © 2018 HealthDay. All rights reserved.
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
Latest Alzheimer’s News TUESDAY, April 2, 2019 (HealthDay News) — Brain scans can improve diagnosis and management of Alzheimer’s disease, a new study claims. Researchers assessed the use of PET scans to identify Alzheimer’s-related amyloid plaques in the brain. The study included more than 11,000 Medicare beneficiaries with mild thinking impairment or dementia of uncertain cause. This scanning technique changed the diagnosis of the cause of mental impairment in more than one-third of the participants in the study. The brain scan results also changed management — including the use of medications and counseling — in nearly two-thirds of cases, according to the study published April 2 in the Journal of the American Medical Association. “These results present highly credible, large-scale evidence that amyloid PET imaging can be a powerful tool to improve the accuracy of Alzheimer’s diagnosis and lead to better medical management, especially in difficult-to-diagnose cases,” said study co-author Maria Carrillo, chief science officer of the Alzheimer’s Association. “It is important that amyloid PET imaging be more broadly accessible to those who need it,” she added in an association news release. Funding for the study came from Avid Radiopharmaceuticals Inc., General Electric Healthcare, and Life Molecular Imaging. “We are […]
New research, published in the journal Nature Genetics, identifies new genetic risk factors for Alzheimer’s disease. It also uncovers novel biological mechanisms that may lead to this neurodegenerative condition. Scientists have found new genetic locations associated with Alzheimer’s. About 5.7 million people in the United States are currently living with Alzheimer’s disease. A recent report issued by the Centers for Disease Control and Prevention (CDC) predicts that by the year 2060, this number will grow to 13.9 million. Genes play an important role in whether a person will develop Alzheimer’s or not. Researchers estimate that 60–80 percent of the disease is heritable. Therefore, identifying the genes that put some people at risk of Alzheimer’s is an important scientific endeavor. So far, studies have found more than 20 genetic locations that have links with the condition, but these only explain a small percentage of the genetic variance that accounts for Alzheimer’s. So, a team of scientists has set out to uncover more genetic risk factors. Professor Danielle Posthuma, from the Vrije Universiteit University in Amsterdam, Netherlands, together with Dr. Ole Andreassen from the University of Oslo, Norway, and Dr. Stephan Ripke from the Broad Institute in Boston, MA, led the new […]
Mushrooms are a much-loved ingredient in cuisines around the world. They are nutritious and especially rich in antioxidants, which protect cell health. Researchers are now asking whether mushrooms can also protect against cognitive decline. Eating mushrooms may help keep cognitive decline at bay. Mushrooms are fascinating. Although some are edible and grocery stores sell them in their “vegetable” aisles, they aren’t actually vegetables. They are actually fungi, a kingdom all of its own, alongside those of plants and animals in biological classifications. Edible mushrooms — both cultivated and wild species — contain a high amount of dietary fiber, antioxidants, and protein, as well as vitamins and minerals. New research has found that people who integrate mushrooms into their diets — even if they only consume them in small portions — appear to have a lower risk of mild cognitive impairment (MCI), which often precedes Alzheimer’s disease. In MCI, a person may experience some symptoms characteristic of Alzheimer’s disease — such as poor memory and issues with language and spatial orientation — but in a much subtler way that does not prevent them from continuing to lead a fully functional life. Researchers at the National University of Singapore (NUS) near Clementi […]
Ketogenic, or keto, diets are low-carb and fat-rich, and many people who follow such regimens do it to shed excess weight. However, a keto diet may bring other benefits, too. In particular, it may help keep the brain healthy and young, as new research in mice seems to suggest. Can a keto diet protect brain health, and if so, how? A keto diet is high in fat, low in carbohydrates, and has an adequate amount of protein. This kind of diet is meant to trigger ketosis, which is a metabolic process through which the body breaks down fat and protein and transforms them into energy, leading to weight loss. Besides triggering weight loss, a keto diet may also bring other health benefits, as studies have recently suggested. For instance, one such study argued that keto diets could help reduce the side effects of certain cancer therapies. Now, researchers from the Sanders-Brown Center on Aging at the University of Kentucky in Lexington, KY, are assessing evidence suggesting that keto diets may also help stave off cognitive decline. The scientists conducted two studies, both in mice. The findings indicate that keto-type diets can protect neurovascular function, as well as metabolic function, in […]
Latest Alzheimer’s News THURSDAY, May 16, 2019 (HealthDay News) — Mornings spent figuring out Sudoku or finessing a crossword could spell better health for aging brains, researchers say. In a study of over 19,000 British adults aged 50 and over who were tracked for 25 years, the habit of doing word or number puzzles seemed to help keep minds nimble over time. “We’ve found that the more regularly people engage with puzzles such as crosswords and Sudoku, the sharper their performance is across a range of tasks assessing memory, attention and reasoning,” said research leader Dr. Anne Corbett, of the University of Exeter Medical School. “The improvements are particularly clear in the speed and accuracy of their performance,” she added in a university news release. “In some areas, the improvement was quite dramatic — on measures of problem-solving, people who regularly do these puzzles performed equivalent to an average of eight years younger compared to those who don’t.” Does that translate to protection against Alzheimer’s and other forms of dementia? The study “can’t say” at this point, Corbett said, “but this research supports previous findings that indicate regular use of word and number puzzles helps keep our brains working better […]
A recent article raises important questions about the prevalence of firearms in the aging population of the United States. The authors argue that there is a vital need to discuss the relationship between dementia and guns. A recent article investigates the issue of gun ownership in an aging population. Gun ownership is a controversial topic, and people are sure to continue debating it for many years to come. This debate often focuses on young men and violent crime, but a recent article investigates the other end of the age spectrum. Older adults are more likely to own a gun than younger people. An estimated 27 percent of people over the age of 65 years own at least one gun, while 37 percent live in a home where a firearm is present. A seemingly unrelated but equally hot topic is the rise of dementia. Dementia and firearms As dementia occurs almost exclusively later in life, the longer that people live, the more prevalent it becomes. Currently, around 5.7 million people in the U.S. are living with Alzheimer’s disease. Although Alzheimer’s is the most common form of dementia, it only accounts for 60–80 percent of all dementia cases. A recent article in […]
Despite decades of research, Alzheimer’s disease still holds many mysteries. A recent study asks whether spontaneous changes to the chemistry of proteins might help explain the neurological hallmarks of Alzheimer’s. A new study looks at the chemistry of Alzheimer’s-related proteins. Alzheimer’s disease is the most common form of dementia; it currently affects an estimated 5.5 million people in the United States. As it stands, there is no cure, and researchers are still trying to come to grips with what makes Alzheimer’s tick. The main focus of medical research has been plaques and tangles, the protein-based markers of the Alzheimer’s brain. A recent paper, published in ACS Central Science, asks whether these features might occur due to what they refer to as “spontaneous chemistry.” Plaques and tangles Plaques consist of a protein called beta-amyloid. Usually, this protein is cleared away by cells, but in the Alzheimer’s brain, it sticks together in clumps between nerve cells. A protein called tau forms neurofibrillary tangles, which develop inside brain cells. Tau is associated with microtubules, which are long, thin, tubular structures that provide support to the cell. In Alzheimer’s, tau is altered, and microtubules cannot form correctly; instead, they form twisted filaments. Despite a […]
Neurodegenerative diseases, such as Alzheimer’s and Huntington’s, share a mechanism of brain cell damage that could offer a new target for treatment, according to new research in human cells and mice. A newly discovered mechanism of brain cell damage could hold the key to treating several neurodegenerative conditions. A recent Nature Neuroscience study describes how researchers uncovered the mechanism and how it leads to death of neurons, or nerve cells. “We’ve identified a potential new way to reduce nerve cell death in a number of diseases characterized by such losses,” says senior study author Daria Mochly-Rosen, Ph.D., a professor of chemical and systems biology at Stanford University School of Medicine, in California. The mechanism involves microglia and astrocytes, two types of cell that normally help to protect neurons, or nerve cells. Microglia and astrocytes are glial cells, a type of cell that scientists once regarded as the “glue of the nervous system.” That is no longer the case, however, as researchers are increasingly discovering that glial cells play vital roles in brain development and function. Among the many jobs that astrocytes fulfill is to determine the number and locations of the connections that neurons make with each other. These glial […]
Latest Alzheimer’s News MONDAY, Dec. 17, 2018 (HealthDay News) — Lots of Americans will unwrap a scarf or sweater this holiday season. But a growing number will receive a gift that’s potentially life-changing: an at-home genetic testing kit. Home DNA testing yields clues to ancestry and, potentially, genetic risk for medical conditions. But there are a number of things you need to know before you use one of these kits, the Alzheimer’s Foundation of America says. “Genetic testing kits are a popular gift, but the test results can have implications that last long after the holidays,” Lori Frank said in a foundation news release. She’s on the foundation’s medical, scientific and memory screening advisory board. “As with any health decision, consumers should have the right information before deciding to take a genetic test,” Frank said. Because genetic testing has potentially positive and negative impacts, the foundation offers some tips: Be informed. “Some people find the results upsetting and are concerned about the emotional impact to relatives with similar genetic risk, while others feel empowered to proactively take better care of their own health. It’s important to consider all impacts beforehand,” said Dr. J. Wesson Ashford, chair of the medical, scientific […]
For many years, specialists believed that people who studied more and kept their brains more active had lower dementia risk. Some recent studies have contradicted this idea. So how is education linked to the evolution of Alzheimer’s disease, if at all? Another study suggests that there is no link between a person’s level of education and Alzheimer’s-related cognitive decline. In the recent past, researchers have argued that people who continue their education throughout their lives have a lower risk of developing Alzheimer’s disease, which is the most common form of dementia and primarily characterized by progressive memory loss. However, studies published this year have found no evidence in support of this conclusion. A high level of education is supposed to boost a person’s cognitive reserve, which refers to the brain’s ability to preserve and maintain cognitive function despite any damage. A high cognitive reserve should act as a safeguard against cognitive impairment, which can occur naturally, as a person ages. But is it really effective in preventing or slowing down the development of Alzheimer’s disease? New research — conducted by Dr. Rebecca Gottesman, from The Johns Hopkins University School of Medicine, in Baltimore, MD, and colleagues — has found no […]
New research that aimed to highlight the potential of new technologies to diagnose disease has suggested that virtual reality may play a crucial role in monitoring Alzheimer’s disease. VR headsets may soon serve as a better alternative to standard testing for Alzheimer’s. Dementia is a general term to describe the impairment of cognitive functions such as memory, thinking, and communication. The cognitive decline associated with dementia is progressive, and people may go through different stages. Mild cognitive impairment (MCI) is an early stage of dementia, but some people with MCI do not develop Alzheimer’s disease. MCI can result from anxiety or normal aging, so it is important to establish the cause to evaluate the risk of dementia. Alzheimer’s is the most common type of dementia. According to the World Health Organization (WHO), about 50 million people in the world have dementia. Doctors diagnose dementia in around 10 million people every year, and 60–70% of these new diagnoses detect Alzheimer’s disease. Several cognitive tests can assess dementia, but recently, researchers have been exploring the potential of new technologies to monitor the condition. A new study from Cambridge University in the United Kingdom — the results of which now appear in the […]
Researchers are finding new evidence that exercise — even low-intensity, casual physical activity — can boost brain health in the short- and long-term. Frequent but leisurely exercise can boost brain health. Evidence that exercise can benefit the brain and help maintain cognitive function — including memory — is accumulating. One study, for instance, suggests that engaging even in low-level phyisical activities, such as doing household chores, can help reduce the risk of cognitive impairment in older adults. Now, a team led by Michelle Voss — from the University of Iowa in Iowa City — has found evidence in support of the notion that the benefits of just one workout can predict the benefits of frequent physical activity in the long run. The team presented these findings at this year’s Cognitive Neuroscience Society’s symposia in San Francisco, CA. As symposium chair Wendy Suzuki, of New York University in New York City, explains, “There is a strong and direct link between physical activity and how your brain works.” “People still do not link physical health to brain and cognitive health; they think about fitting into a bikini or losing that last pound, not about all the brain systems they are improving and […]
Dementia and Alzheimer’s disease are similar but not the same. Dementia is a general term and has many different types, of which Alzheimer’s is one. There is sometimes confusion between the two because people often use the terms interchangeably. Dementia is an umbrella term used to describe a set of symptoms that broadly affect cognitive functioning, including: memory thinking and focus problem solving language visual perception Alzheimer’s disease is a specific type of dementia that causes a gradual decline in memory and thinking. What is dementia? Some dementia symptoms can be mild and difficult to detect. Dementia is a syndrome, which means that it describes a collection of symptoms with no specific cause. A syndrome is different from a disease, which has specific symptoms and a common cause. Dementia can affect a wide range of mental functions. As a result, many different diseases and conditions are types of dementia. Alzheimer’s disease is the most common form of dementia, but there are several other types, including: vascular dementia, which results from strokes or other conditions that block blood flow to the brain Lewy body dementia, which is a result of abnormal protein deposits in the brain frontotemporal disorders, which are types […]
Brain atrophy refers to a loss of brain cells or a loss in the number of connections between brain cells. People who experience brain atrophy typically develop poorer cognitive functioning as a result of this type of brain damage. There are two main types of brain atrophy: focal atrophy, which occurs in specific brain regions, and generalized atrophy, which occurs across the brain. Brain atrophy can occur as a result of the natural aging process. Other causes include injury, infections, and certain underlying medical conditions. This article describes the symptoms and causes of brain atrophy. It also outlines the treatment options available in each case, as well as the outlook. Brain atrophy can affect one or multiple regions of the brain. The symptoms will vary depending on the location of the atrophy and its severity. According to the National Institute of Neurological Conditions and Stroke, brain atrophy can cause the following symptoms and conditions: Seizures A seizure is a sudden, abnormal spike of electrical activity in the brain. There are two main types of seizure. One is the partial seizure, which affects just one part of the brain. The other is the generalized seizure, which affects both sides of the […]
Researchers are growing increasingly interested in the relationship between blood pressure and dementia. The most recent study investigates how patterns of change in blood pressure over the decades might influence risk. What can blood pressure fluctuations tell us about dementia risk? As the United States population ages, dementia incidence rises in tandem. Today, around 5 million people in the U.S. have a dementia diagnosis. Studies published over the last few years have produced evidence that hypertension (high blood pressure) during midlife appears to increase the risk of dementia and cognitive decline. Hypertension affects an estimated 1 in 3 adults in the U.S., so it is vital to understandi the exact relationship between blood pressure and the aging brain. Researchers have done less work to investigate the links between blood pressure during later life and cognitive outcomes. However, as the authors of a recent study explain, the findings hint that “optimal blood pressure ranges for older adults may depend on earlier blood pressure characteristics.” In other words, the impact of hypertension on the aging brain may depend on the pattern of blood pressure from midlife onward. Blood pressure changes through life The authors of the current study, published in JAMA Network, […]
By Deborah DiSesa HirschHealthDay Reporter Latest Alzheimer’s News TUESDAY, Oct. 29, 2019 (HealthDay News) — Unpaid bills, overdrawn accounts, dwindling investments: When seniors begin experiencing fiscal troubles, early dementia or Alzheimer’s disease could be an underlying cause, researchers say. In the early stages of the disease, people with undiagnosed Alzheimer’s are at high risk of making foolish and dangerous decisions about their finances, mostly because families may not know they need help, researchers say. “Individuals often aren’t diagnosed early enough, and it’s a perfect storm,” said study author Carole Gresenz, a professor of health systems administration at Georgetown University in Washington, D.C. “They’re vulnerable to large reductions in liquid assets because they’re not making wise decisions about their finances, savings and checking accounts. This can also reduce net wealth,” added Gresenz. Ruth Drew, director of information and support services for the Alzheimer’s Association, pointed out that Alzheimer’s destroys the brain. “As the disease progresses, everyone with Alzheimer’s will reach a point where they need help with their finances and ultimately assistance with daily tasks and around-the-clock care. We have certainly spoken to people whose finances were significantly affected,” she said. In some cases, people responsible for making major financial decisions, […]
If you buy something through a link on this page, we may earn a small commission. How this works. Coenzyme Q10, or CoQ10, is a naturally occurring chemical that exists in almost every cell of the human body. CoQ10 carries out several vital roles, including promoting energy production and neutralizing harmful particles called free radicals. A deficiency in CoQ10 can adversely affect a person’s health. People can get CoQ10 through foods and supplements. In this article, we discuss the benefits, side effects, and recommended dosages of CoQ10. Share on PinterestNuts are one of the foods that contain CoQ10. CoQ10 is an essential nutrient present in almost every cell of the human body. The following foods also contain CoQ10: CoQ10 plays a vital role in energy production and DNA replication and repair. It also acts as an antioxidant, neutralizing harmful free radicals. Several factors can lower CoQ10 levels in the body. These include: aging taking statins, which are cholesterol-lowering medications genetic mutations that affect the production of CoQ10 disorders of the mitochondria, which are the parts of the cell that generate energy CoQ10 deficiency is associated with numerous diseases, including: For the body to use CoQ10, it must convert it from […]
A new drug for treating Alzheimer’s disease has successfully passed the first phase of testing in humans. Preclinical studies had already shown that the drug could improve memory and other symptoms of Alzheimer’s disease in older mice. A potential treatment for Alzheimer’s moves a step closer. Researchers at Forschungszentrum Jülich and Heinrich Heine University Düsseldorf, both in Germany, developed the candidate drug, which, for now, bears the name PRI-002. PRI-002 eliminates toxic beta-amyloid oligomers, the self-replicating proteins that scientists suspect of causing and advancing Alzheimer’s disease. The team had previously shown that the drug could significantly reduce signs and symptoms in older mice that were genetically engineered to develop an Alzheimer’s-like disease through the insertion of a mutant human gene. That preclinical study featured online in 2018 in the journal Molecular Neurobiology. In the ensuing, recently completed phase 1 clinical trial, healthy volunteers took daily dosages of PRI-002 for 4 weeks. The results show that the drug is safe for human use. Passing this stage of testing in humans means that the candidate drug can now proceed to a phase 2 trial to evaluate its effectiveness in people with Alzheimer’s disease. “Our next goal is the proof of efficacy in […]
For the first time, a new study has observed that cerebrospinal fluid washes in and out of the brain in waves during sleep, helping clear out waste. Cerebrospinal fluid helps clear toxic waste from the brain during sleep. Recently, Medical News Today reported on a study that found that specialized immune cells are more active in the brain during sleep, busy performing maintenance work. Researchers know that sleep is important — not just in terms of allowing the brain to reactualize, but also for “making space” for “cleaning” processes to take place. However, many of the mechanisms through which this clearing out of brain waste takes place during sleep remain unclear. Now, researchers at Boston University in Massachusetts have found that during sleep, the fluid present in the brain and spinal chord — called the cerebrospinal fluid — washes in and out, like waves, helping the brain get rid of accumulated metabolic “trash.” “We’ve known for a while that there are these electrical waves of activity in the neurons. But before now, we didn’t realize that there are actually waves in the cerebrospinal fluid, too,” study co-author Laura Lewis explains. A complex synchronization process The new study — the results […]
Latest Alzheimer’s News TUESDAY, Nov. 12, 2019 (American Heart Association News) — Omega-3 fatty acids have drawn attention for their potential to keep people’s thinking sharp as they age, and new research appears to support that notion for some heart patients. The study found taking omega-3 fatty acid supplements was associated with better brain function in people with coronary artery disease, which increases risk for dementia. The study included 250 people with coronary artery disease. For 30 months, half took omega-3 supplements; the other half served as a control group. The group taking the supplements had better coordination, reaction speed, memory and recall at one year and at 30 months, compared to the control group. “Other researchers have looked at omega-3 fatty acids in people who already have cognitive impairment or dementia,” said Dr. Francine Welty, a cardiologist at Harvard Medical School in Boston and one of the study’s investigators. “But the people we looked at were cognitively healthy, and we found there may be a benefit from omega-3 fatty acids before cognitive decline begins.” Welty’s colleague, Dr. Bhavya Vemuri, will present the preliminary findings Saturday at the American Heart Association’s Scientific Sessions in Philadelphia. Omega-3 fatty acids help build […]
A blood test can identify the protein that builds up in the brains of people with Alzheimer’s nearly 20 years before symptoms appear, a new study shows. A simple blood test could soon predict symptoms of Alzheimer’s disease decades before they appear. The study found that the blood test was even more sensitive at detecting the buildup of beta-amyloid proteins in the brain than the current gold standard, which is a PET brain scan. Researchers from Washington University School of Medicine (WUSTL) in St. Louis, MO, conducted the study, which appears in the journal Neurology. First author Dr. Suzanne Schindler, an assistant professor of neurology, led the researchers, who first developed a version of this test a couple of years ago. The test uses mass spectrometry on blood samples to detect the presence of two forms of the beta-amyloid protein: beta-amyloid 42 and beta-amyloid 40. When beta-amyloid deposits in the brain start to build up, the ratio between the two forms of the protein goes down. The blood test can detect this change. The study involved 158 adults who were at least 50 years old, and all but 10 had normal cognitive function. For the study, each person had a […]
Latest Alzheimer’s News FRIDAY, May 10, 2019 (HealthDay News) — Cuddler the bear, Aibo the dog, Justocat the purring kitty: They may only be furry, lifelike robots, but they have a made a real impact in nursing homes. That’s the finding of new British research that suggests these high-tech “robopets” are the next best thing for nursing home residents unable to have a beloved pet or those suffering from loneliness. “Although not every … resident may choose to interact with robopets, for those who do, they appear to offer many benefits,” study author Rebecca Abbott, of the University of Exeter Medical School, said in a university news release. The robopets stimulate conversations and trigger fond memories of pets or past experiences, Abbott said. “And there is also the comfort of touching or interacting with the robopet itself. The joy of having something to care for was a strong finding across many of the studies.” One U.S. geriatrician who was not involved in the study said engagement with a robotpet does seem helpful. “Most importantly, it was found to decrease loneliness and increase pleasure and joy, and bring comfort,” said Dr. Maria Torroella Carney. She directs geriatrics and palliative medicine at […]
Latest Alzheimer’s News MONDAY, Aug. 12, 2019 (HealthDay News) — New research is untangling the complex relationship between symptoms of depression and losses in memory and thinking that often emerge together with Alzheimer’s disease. In fact, the new data suggests that “depression symptoms themselves may be among the early changes in the preclinical stages of dementia syndromes,” explained study lead author Dr. Jennifer Gatchel. She works in the division of geriatric psychiatry at Massachusetts General Hospital in Boston. In the study, researchers examined brain scans and other data gathered over seven years from 276 older adults enrolled in the Harvard Aging Brain Study. All of the participants were still living independently in the community at the beginning of the study and were considered healthy. However, the analysis revealed a significant link between worsening depression symptoms and mental decline over two to seven years, and both of these trends seemed to be linked to a buildup of amyloid protein in brain tissue. The slow accumulation of amyloid has long been known as a hallmark of Alzheimer’s disease. “Our research found that even modest levels of brain amyloid deposition can impact the relationship between depression symptoms and cognitive [thinking] abilities,” Gatchel said […]
Blocking an enzyme could put a stop to the buildup of toxic protein clumps that occurs in the brains of people with Parkinson’s disease. New research reveals that blocking a certain protein clears Lewy bodies — toxic structures that are a hallmark of Parkinson’s disease. This was the conclusion that scientists at Georgetown University Medical Center (GUMC) in Washington, D.C. reached after studying the enzyme, called USP13, in the brains of mice and humans. The study, which features in the journal Human Molecular Genetics, may be the first to explain USP13’s role in the toxic accumulation of protein clumps in the brain. The protein accumulations are called Lewy bodies, and they also occur in other neurodegenerative diseases, including Lewy body dementia and multiple system atrophy. “This study,” says lead author Xiaoguang Liu, an assistant professor of neurology at GUMC, “provides novel evidence that USP13 affects development and clearance of Lewy body protein clumps, suggesting that targeting USP13 may be a therapeutic target in Parkinson’s disease and other similar forms of neurodegeneration.” Parkinson’s disease and Lewy bodies Parkinson’s disease is a degenerative disorder that chiefly affects movement control. Typical symptoms include tremors, stiffness, and bradykinesia, which is a slowness of movement. […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Oct. 30, 2019 (HealthDay News) — If you were good with words and puzzles at age 8, you’re likely to fare well on tests of mental acuity at age 70, too. That’s among the findings of a new study that followed the thinking abilities of a group of Britons born in the 1940s. Researchers found that their performance on standard cognitive tests at age 8 predicted their performance around age 70. People who scored in the top quarter as kids were likely to remain in that bracket later in life. “Cognition” refers to our ability to pay attention, process information, commit things to memory, to reason and to solve problems. And it’s no surprise, experts said, that there is a correlation between childhood and adulthood skills. However, no one is saying that your brain-health destiny is set in childhood, according to senior researcher Dr. Jonathan Schott, a professor of neurology at University College London. In this study, for example, education also mattered. Older adults who’d gone further in their formal education tended to score higher, regardless of their test performance as children. A number of past studies have linked higher education levels […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News TUESDAY, April 30, 2019 (HealthDay News) — Elderly adults commonly have memory and thinking problems that look a lot like Alzheimer’s disease, but they might really be suffering from a different form of dementia. That’s according to an international panel of experts who are giving the disease a name for the first time, and detailing what’s known about it so far. Writing in the April 30 issue of the journal Brain, they dub the condition limbic-predominant age-related TDP-43 encephalopathy — with the more memorable acronym, LATE. LATE mainly affects people older than 80, the experts explained. And it may account for about 17% of all cases of dementia. That fairly high prevalence helps explain a puzzling phenomenon, according to Dr. Peter Nelson, a professor at the University of Kentucky, who co-authored the report. Some people who die with what appears to be Alzheimer’s do not show telltale signs of the disease when their brains are autopsied — namely, abnormal protein clumps known as plaques and tangles. That means their dementia symptoms did not arise from Alzheimer’s. “This is part of a growing understanding that not all dementias are the same,” Nelson said. As […]
An analysis of how the retina of the eye scatters light shows promise as an aid for the early diagnosis of Alzheimer’s disease. Share on PinterestExamining how the retina disperses light can provide insight into Alzheimer’s disease. Scientists from the University of Minnesota in Minneapolis came to this conclusion after carrying out a recent study, the findings of which appear in ACS Chemical Neuroscience. The researchers investigated retinal hyperspectral imaging (HSI) as a potential technique for early Alzheimer’s detection in 35 people. HSI is an emerging imaging method in medicine. As a diagnostic aid, it can provide valuable information about tissue composition and structure. Scientists can take HSI scans of the retina using a special camera that attaches to a spectral imaging system. The method, which takes about 10 minutes to administer, is noninvasive and does not require the injection of tracer substances. Need for biomarkers of early Alzheimer’s Alzheimer’s disease is responsible for 60–80% of cases of dementia, an incurable condition that progressively impairs memory and thinking to the point that independent living is no longer possible. The presence of toxic clumps of beta-amyloid protein in the brain is an established hallmark of Alzheimer’s disease. If there was a […]
Leg shaking can be a subtle annoyance or an intense experience that causes muscle tension and difficulty walking. Many issues, ranging from restless legs syndrome (RLS) to serious conditions such as dementia, can cause someone’s leg to shake. It is not possible to diagnose the cause of shaky legs based on symptoms alone. For this reason, people who experience leg shaking should speak to a doctor or healthcare provider. Keep reading this article to learn about 10 possible causes of leg shaking. Share on PinterestA tremor is a possible cause of leg shaking. A tremor is an involuntary muscle contraction. The contraction is rhythmic, so a person might feel the muscle shaking or moving at predictable intervals. A person with a leg tremor may notice their leg shaking while a muscle or group of muscles pulses or spasms out of control. The tremor may last for a few minutes, or it may be an ongoing problem. Numerous medical conditions can cause a tremor. They are often those that damage the neurological system, including: Liver and kidney failure may also cause tremors. A rare type of tremor, called primary orthostatic tremor, specifically affects the legs. People with this condition notice a […]
A new study finds that people with Alzheimer’s disease who also took antidiabetes medication exhibited fewer molecular markers of the neurological condition. These findings could inform future Alzheimer’s treatments. A study examined the molecular pathways of brain tissue and the cells that line the inside of blood vessels in the brains of people with Alzheimer’s and diabetes. New research — led by Vahram Haroutunian, Ph.D., a professor of psychiatry and neuroscience at the Icahn School of Medicine at Mount Sinai in New York City, NY — analyzed the brain tissues of people who had both Alzheimer’s disease and diabetes. The findings suggest that antidiabetes drugs may protect the brain against Alzheimer’s. As Prof. Haroutunian and colleagues explain in their paper, a mounting body of evidence has been pointing to a link between the risk of mild cognitive impairment, dementia, and type 2 diabetes. Additional studies have uncovered an association between an insulin receptor pathway in the brain and the accumulation of Alzheimer’s-specific brain pathologies. Previous studies conducted by the same Prof. Haroutunian and colleagues found that the brains of people with Alzheimer’s who had also undergone treatment for diabetes, such as insulin or antidiabetes medicine, had reduced brain pathologies. So, […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — Even if you are at high risk for Alzheimer’s disease, a little more exercise may buy you time, new research suggests. Folks with elevated levels of a brain protein called beta amyloid tend to be more likely to develop Alzheimer’s disease and experience rapid brain decline later in life, previous research has found. But apparently they can delay the onset of Alzheimer’s through regular exercise, scientists report. “People who had elevated levels of amyloid, which is one of the earliest changes you see with Alzheimer’s disease, had slower rates of cognitive decline and brain volume loss over time if they had greater levels of physical activity,” said lead researcher Jennifer Rabin. She is a scientist with the Hurvitz Brain Sciences Program at the Sunnybrook Research Institute in Toronto. It didn’t take much exercise to enjoy this protection, either. The data suggests that people who walked 8,300 to 8,900 steps per day significantly delayed the onset of Alzheimer’s, Rabin said. Previous studies have shown that older people who exercise generally tend to stay sharp longer into old age, but this new research shows physical activity is specifically […]
Latest Alzheimer’s News WEDNESDAY, Jan. 9, 2019 (HealthDay News) — Poor sleep is common among Alzheimer’s patients, and researchers say they’re beginning to understand why. Scientists studied 119 people aged 60 and older. Eighty percent had no thinking or memory problems, while the rest had only mild problems. The researchers found that participants with less slow-wave sleep — deep sleep that’s needed to preserve memories and to wake up feeling refreshed — had higher levels of the brain protein tau. Elevated tau levels are a possible sign of Alzheimer’s disease and have been linked to brain damage and mental decline, the scientists said. The findings suggest that poor sleep among older adults could be a warning sign of declining brain health, according to the researchers at Washington University School of Medicine in St. Louis. “We saw this inverse relationship between decreased slow-wave sleep and more tau protein in people who were either cognitively normal or very mildly impaired, meaning that reduced slow-wave activity may be a marker for the transition between normal and impaired,” said first author Dr. Brendan Lucey. He’s an assistant professor of neurology and director of the Washington University Sleep Medicine Center. “Measuring how people sleep may […]
Latest Alzheimer’s News MONDAY, Nov. 25, 2019 (HealthDay News) — Air pollution may trigger Alzheimer’s-like brain changes and speed memory decline in older adults, a new study suggests. Previous research has implied that exposure to fine particle air pollution increases the risk of Alzheimer’s disease and other types of dementia, but it wasn’t clear how this type of pollution affects the brain and memory. “This is the first study to really show, in a statistical model, that air pollution was associated with changes in people’s brains and that those changes were then connected with declines in memory performance,” said researcher Andrew Petkus. He’s an assistant professor of clinical neurology at the University of Southern California’s Keck School of Medicine. “Our hope is that by better understanding the underlying brain changes caused by air pollution, researchers will be able to develop interventions to help people with or at risk for cognitive decline,” Petkus explained in a university news release. The study included nearly 1,000 women, aged 73 to 87, who had brain scans five years apart. The researchers also assessed information about where the women lived and environmental data from those locations to estimate the women’s exposure to fine particle pollution. […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, April 10, 2019 (HealthDay News) — Amyloid beta has long been a prime suspect in Alzheimer’s disease, since abnormal levels of the protein form disruptive plaques between patients’ brain cells. But drug trials aimed at lowering amyloid levels have repeatedly failed to save people’s brains, and some researchers now believe the focus needs to shift to other potential culprits. Researchers pulled the plug early on the latest failed clinical trial, after patients’ brain power continued to decline even though the amyloid beta blocker verubecestat successfully lowered amyloid levels in their brains and spinal fluid. The disappointing verubecestat results appear in the April 11 issue of the New England Journal of Medicine, alongside a research letter announcing similarly negative preliminary findings from the clinical trial of another amyloid blocker called atabecestat. These negative results jibe with those of earlier trials, and present “pretty strong evidence that amyloid-lowering is the wrong target,” said Dr. David Knopman. He’s a professor of neurology with the Mayo Clinic who wrote an editorial accompanying the new reports. Knopman noted that the verubecestat trial showed that amyloid levels declined slightly in the brain and fairly substantially in the spinal […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News MONDAY, Nov. 4, 2019 (HealthDay News) — Could one woman’s rare genetic mutation one day have a global impact on dementia risk? It’s possible, say investigators who report on a potentially groundbreaking case of a woman whose genetic mutation staved off dementia for decades, even though her brain had already been damaged by Alzheimer’s disease. While most Alzheimer’s cases are not driven by genetic predisposition, one woman in Colombia is among about 1,200 in her country who do face a genetically higher risk for early-onset Alzheimer’s. Why? They all carry the E280A mutation of a gene called Presenilin 1 (PSEN1), which is known to increase the chances for Alzheimer’s at a far younger age than usual. “We identified an individual that was predisposed to develop Alzheimer’s in her 40s,” noted study author Dr. Joseph Arboleda-Velasquez. He’s an assistant professor of ophthalmology with the Schepens Eye Research Institute of Mass Eye and Ear at Harvard Medical School, in Boston. But, strangely, the woman “remained unimpaired until her 70s,” Arboleda-Velasquez added. The twist: the woman had, in fact, developed clear telltale signs of Alzheimer’s in her brain. She just hadn’t developed dementia. For example, while […]
Regular exposure to stress can impact our physical and mental health, but how does it actually affect our brains? One new Harvard Medical School study answers that question. According to new research, high levels of stress hormones can impact how well the brain functions. Stress — especially when we experience it on a regular basis — takes a significant toll on our minds and bodies. It can make us feel more irritable and constantly tired, and it impacts our ability to focus. Chronic stress can also interfere with our sleep patterns, appetite, and libido, and it can also exacerbate a range of health conditions. These include diabetes, heart disease, and gastrointestinal problems. One study that Medical News Today covered earlier this year, in fact, saw that even minor levels of distress can increase a person’s risk of chronic disease. What impact does stress have on the brain in physiological and cognitive terms? Researchers from Harvard Medical School in Boston, MA, have explored this question and reported their answer in the journal Neurology. The stress hormone affects memory In their study, the researchers worked with participants with an average age of 49 and no diagnosis of dementia. At baseline, the investigators […]
New research identifies changes in the neurochemistry and anatomy of the brain that occur decades before people experience any symptoms of Alzheimer’s disease. Brain changes may occur decades before people experience Alzheimer’s symptoms, accumulating evidence suggests. The fact that more than 35 million people are currently living with Alzheimer’s disease has led some experts to refer to this condition as a “global epidemic.” According to estimates, the prevalence of Alzheimer’s disease will double almost every 2 decades. Detecting Alzheimer’s early on makes it easier to plan adequate care and begin therapeutic interventions as early as possible, which may alleviate the symptoms. Researchers believe that Alzheimer’s begins many years before the onset of symptoms. In fact, emerging research has suggested that some Alzheimer’s-related brain mechanisms start at least 10 years before diagnosis. However, it is not yet clear exactly when these changes occur. In a new study, researchers have set out to detect more precise “changepoints” in the evolution of Alzheimer’s biomarkers. Laurent Younes, Ph.D., who is a professor and chair of the Department of Applied Mathematics and Statistics at Johns Hopkins University in Baltimore, MD, is the lead author of the new paper, which appears in the journal Frontiers in […]
Scientists have now proved that drinking certain types of coffee can be beneficial to brain health, but how does this popular brew support cognitive function? A new study identifies some of the mechanisms that allow coffee to keep mental decline at bay. What makes coffee an ally of brain health? According to data from the Harvard T.H. Chan School of Public Health in Boston, MA, about 54 percent of all adults in the United States drink coffee on a daily basis. While drinking coffee can bring both benefits and risks for a person’s health, a 2016 study from the University of Ulster in Coleraine, United Kingdom, concluded that the health benefits of moderate coffee consumption “clearly outweigh” the potential risks. One of these benefits is that coffee seems to protect the brain against cognitive impairments and boost thinking skills. How does this happen, and what is it about coffee that is so beneficial to cognitive health? These are some questions that a new study from the Krembil Brain Institute — part of the Krembil Research Institute in Toronto, Canada — aims to answer. “Coffee consumption does seem to have some correlation to a decreased risk of developing Alzheimer’s disease and […]
Latest Alzheimer’s News TUESDAY, Jan. 22, 2019 (HealthDay News) — Leaky blood vessels in the brain may be an early sign of Alzheimer’s disease, researchers say. They followed 161 older adults for five years and found that those with the most severe memory declines had the greatest leakage in their brain’s blood vessels, regardless of whether the Alzheimer’s-related proteins amyloid and tau were present. The findings could help with earlier diagnosis of Alzheimer’s and suggest a new drug target for slowing down or preventing the disease, according to the researchers from the University of Southern California. “The fact that we’re seeing the blood vessels leaking, independent of tau and independent of amyloid, when people have cognitive [mental] impairment on a mild level, suggests it could be a totally separate process or a very early process,” said study senior author Dr. Berislav Zlokovic. He is director of the Zilkha Neurogenetic Institute at the university’s Keck School of Medicine in Los Angeles. “That was surprising, that this blood-brain barrier breakdown is occurring independently,” Zlokovic added in a university news release. The blood-brain barrier prevents harmful substances from reaching brain tissue. In some people, this barrier weakens with age. “If the blood-brain barrier […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Aug. 21, 2019 (HealthDay News) — Could a pacemaker for the brain improve the memories of people with dementia or Alzheimer’s disease? New research suggests it might be possible one day: Electrical stimulation directed at key memory regions of the brain created intense flashbacks in some Alzheimer’s patients, including sensations of emotions, smells, taste and temperature. In one case, a patient suddenly recalled “an entire experience of being inebriated while drinking a margarita at a resort in Aruba,” researchers said. In another, a man had a vivid flashback of feeling very full after eating sardines on his front porch two decades previously. In fact, about half of the 42 Alzheimer’s patients in the clinical trial experienced electrically induced flashbacks from decades prior, stretching back as far as the Vietnam War era, said lead researcher Dr. Wissam Deeb, an assistant professor of neurology at the University of Florida. “These memory recollections were very vivid for some people,” Deeb said. “They were associated with a lot of emotional content when patients remembered them, because they were memories they hadn’t even thought of for such a long time.” Researchers cautioned that the deep brain stimulation […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News MONDAY, June 17, 2019 (HealthDay News) — Treatment with blood pressure medication can improve blood flow to a key brain region in people with Alzheimer’s disease, a small clinical trial has found. Researchers stressed that they do not know whether the brain finding can translate into any benefits for patients. But future studies should look into that possibility, they said. The findings, published June 17 in the journal Hypertension, come from a trial of 44 patients with mild to moderate Alzheimer’s. They were randomly assigned to take either the blood pressure drug nilvadipine or inactive placebo pills for six months. In the end, patients on the drug showed a 20% increase in blood flow to the hippocampus — a brain structure involved in memory and learning that is one of the first areas damaged by Alzheimer’s. Experts said the study was too small and short-term to know whether the improved blood flow could have any effect on symptoms. But future research should try to answer that question and should focus on people with early Alzheimer’s, said Dr. Jurgen Claassen, the study’s lead author. The research is part of a larger trial that looked […]
By Len CanterHealthDay Reporter Latest Alzheimer’s News THURSDAY, Oct. 24, 2019 (HealthDay News) — If you have a hard time remembering names or what to get at the supermarket, there are ways to boost your memory. According to a study in the journal Consciousness and Cognition, one of the best things you can do is say the information you want to remember out loud, and it’s even stronger if you repeat the information to another person — that means not just mouthing the words. This could explain why you can recite your child’s favorite book unaided — read it out loud enough times and you can have near total recall. An everyday example is to repeat the name of a new acquaintance out loud as soon as you’re introduced. Instead of just saying, “It’s nice to meet you,” add their name and say, “It’s nice to meet you, Mary.” Making word and number associations is effective, too. Break down a phone number you want to memorize into digits you can associate with special dates or the ages of your kids, for example. You might try dividing almost any type of information into chunks that you learn one by one. Other […]
Latest Alzheimer’s News WEDNESDAY, June 5, 2019 (HealthDay News) — If someone you know is struggling to keep track of their finances as they age, early dementia might be the culprit. That’s the conclusion of researchers who tested 243 adults, aged 55 to 90, on their financial skills and performed brain scans to assess the buildup of beta-amyloid plaques, which are associated with Alzheimer’s disease. Some of the participants had no mental decline, some had mild memory impairment and some had been diagnosed with Alzheimer’s disease. Specific financial skills declined with age and at the earliest stages of mild memory impairment, with similar declines in men and women, the study authors said. “There has been a misperception that financial difficulty may occur only in the late stages of dementia, but this can happen early and the changes can be subtle,” said senior study author P. Murali Doraiswamy. He is a professor of psychiatry and geriatrics at Duke University, in Durham, N.C. After accounting for education levels and other factors, the researchers found that the more extensive the amyloid plaques were, the worse a person’s ability to understand and use basic financial concepts or to complete financial tasks, such as calculating […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, May 29, 2019 (HealthDay News) — Here’s another reason to keep your cholesterol under control: New research suggests that LDL, or “bad,” cholesterol may play a role in the development of early-onset Alzheimer’s. A rare form of the disease that occurs before the age of 65, early-onset Alzheimer’s has previously been linked to a gene mutation involved in how the body processes fats and cholesterol. But that mutation only accounts for a small percentage of cases, the scientists noted. Their new research suggests that “LDL cholesterol levels [also] play a causal role in the pathogenesis of Alzheimer’s disease,” said lead researcher Dr. Thomas Wingo. He’s an assistant professor of neurology at Emory University School of Medicine in Atlanta. “The big question is whether there is a causal link between cholesterol levels in the blood and Alzheimer’s disease risk,” Wingo said. “The existing data is murky on this point. Our current work is focused on testing whether there is a causal link.” Most early-onset Alzheimer’s disease is not explained by known gene mutations, Wingo added. The APOE genetic mutation, called APOE E4, raises levels of LDL cholesterol. High levels of this type of […]
Latest Alzheimer’s News MONDAY, Aug. 19, 2019 (HealthDay News) — Heat waves can pose a serious risk to people with Alzheimer’s disease, so their families should know how to keep them safe, advocates say. Extreme heat is “dangerous for everyone, but especially for someone with Alzheimer’s disease, who may be unable to spot the warning signs of trouble or know how to get help,” said Charles Fuschillo Jr., president and CEO of the Alzheimer’s Foundation of America (AFA). “Caregivers need to be proactive and prepared to protect their loved ones. Taking a few simple steps will go a long way,” he said in a foundation news release. Alzheimer’s and other types of dementia can diminish a person’s ability to know when they are thirsty, so it’s crucial for caregivers to watch them and encourage them to drink often. Don’t let them have alcohol and caffeinated beverages, which may contribute to dehydration. Seniors and people with chronic medical conditions are at high risk for hyperthermia, an abnormally high body temperature caused by an inability to regulate heat from the environment. A life-threatening form of hyperthermia is heat stroke, a dangerous elevation in body temperature. Watch Alzheimer’s patients for warning signs such […]
WEDNESDAY, May 15, 2019 (HealthDay News) — Regular exercise, eating a healthy diet, watching your blood pressure, avoiding tobacco and limiting alcohol intake can reduce your risk of dementia, according to World Health Organization guidelines released Tuesday. Latest Alzheimer’s News The WHO also cautioned against taking dietary supplements such as Vitamins B and E in an attempt to prevent mental decline and dementia, CNN reported. Dementia affects 50 million people worldwide and there is no effective treatment. “While some people are unlucky and inherit a combination of genes that makes it highly likely they will develop dementia, many people have the opportunity to substantially reduce their risk by living a healthy lifestyle,” Tara Spires-Jones, U.K. Dementia Research Institute program lead and deputy director of the Center for Discovery Brain Sciences at the University of Edinburgh, U.K. told the Science Media Center, CNN reported. “The WHO has looked at the available evidence and made recommendations that some lifestyle changes, in particular increasing exercise before any cognitive symptoms are present, can reduce dementia risk,” she explained. In terms of healthy eating, the WHO said your best bet is the Mediterranean diet, which emphasizes lots of fruits and vegetables and olive oil, CNN […]
Researchers have found that nilvadipine, a drug that doctors regularly use to treat hypertension, may help people with Alzheimer’s disease by increasing blood flow to the brain. New research suggests that a high blood pressure drug may slow down the progression of Alzheimer’s disease. Alzheimer’s disease is the most common form of dementia. This progressive disorder causes the degeneration and, ultimately, the death of brain cells. People with dementia experience cognitive decline, and have issues making judgments and performing everyday tasks. Dementia affects millions of people worldwide. According to Alzheimer’s Disease International, the number of people with dementia was close to 50 million n 2017, and the organization say this number will almost double every 20 years, reaching 75 million people by 2030. In the United States, Alzheimer’s disease is the sixth leading cause of death. Researchers have been looking for treatments to slow the progression of the disorder and recently found that the hypertension drug nilvadipine may have positive effects on the cerebral blood flow of those with Alzheimer’s disease. The results appear in the journal Hypertension. How nilvadipine affects cerebral blood flow Nilvadipine is a calcium channel blocker that leads to vascular relaxation and lowers blood pressure, and […]
Recent research into older adults confirms that loneliness is tied to a raised risk of developing dementia. The study also reveals that the effect ranges across a diversity of people and is independent of how much social contact they have. A large new study confirms that loneliness is a risk factor for dementia. Scientists from Florida State University (FSU) in Tallahassee used data on 12,030 individuals from the Health and Retirement Study, a United States government-sponsored longitudinal survey of a nationally representative sample of people aged 50 and older. They report their findings in a paper that now features in The Journals of Gerontology: Series B. “We are not the first people,” says first study author Dr. Angelina Sutin, who is an associate professor in FSU’s College of Medicine, “to show that loneliness is associated with increased risk of dementia.” “But this is by far the largest sample yet, with a long follow-up,” she adds. “And the population was more diverse.” The study data contained measures of loneliness and social isolation and a range of risk factors, including behavioral, clinical, and genetic. Through telephone interviews, individuals had also completed assessments of cognitive ability, a low score on which indicates dementia. […]
Recent research reveals that leaky capillaries in the brain could have a role in the development of Alzheimer’s disease. Changes in blood vessel permeability offer new clues about the onset of dementia. Dementia, the main type of which is Alzheimer’s disease, affects about 50 million people worldwide. According to the Alzheimer’s Association, over 5 million people in the United States are living with Alzheimer’s. This number is expected to reach 14 million by 2050. For this reason, it is becoming more and more important to diagnose these health conditions earlier, and to locate new targets for drugs to slow down or prevent the condition. The Food and Drug Administration (FDA) have approved some drugs that help with the symptoms of Alzheimer’s disease, but none of them treat the underlying cause. A new study conducted at the University of Southern California (USC) in Los Angeles could pave the way for new, more effective treatments. The findings now appear in the journal Nature Medicine. Leaky capillaries in the brain Previous studies indicated that two toxic proteins, amyloid and tau, may be “the trigger and bullet” in the development of Alzheimer’s. Findings showed that soluble forms of amyloid and tau work together to […]
There is no link between statin use and memory impairment, researchers have concluded, after evaluating effects of the cholesterol-lowering drugs over 6 years in more than 1,000 older people in Australia. Share on PinterestNew research reinforces the idea that statins are safe for older adults to use. A team from the Garvan Institute of Medical Research and the University of New South Wales (UNSW), both in Sydney, Australia, led the study. “Over 6 years, there was no difference in the rate of decline in memory or global cognition between statin users and never users,” they write in a recent Journal of the American College of Cardiology paper on the findings. In fact, for certain individuals, statins may even offer some protection against memory decline, they suggest. The results show that, among participants with risk factors for dementia, those who used statins had a slower rate of decline in memory and thinking skills than those who did not use the drugs. The researchers hope that the findings will help to allay fears among consumers who have become concerned following reports of isolated cases of statin users experiencing cognitive decline. “Many factors can contribute to the cognitive symptoms that isolated case reports […]
Building on decades of research, a new paper brings us one step closer to a vaccine that targets the neurological hallmarks of Alzheimer’s disease. Prevention may soon be possible. Scientists inch closer to finding a way to prevent Alzheimer’s disease. Alzheimer’s disease, the most common form of dementia, is a degenerative neurological disease. Memory issues are often the first sign of the condition, which steadily progresses over time. Alzheimer’s disease is a growing concern as it appears almost exclusively in older adults. As the number of older people rises in the United States, the number of cases will also increase. Although scientists are still investigating the exact causes of Alzheimer’s disease, they believe that certain neurological markers play a significant role. The disease seems to involve a buildup of specific proteins in the brain called beta-amyloid and tau. Doctors refer to these abnormal congregations as plaques and neurofibrillary tangles respectively. The hunt for a vaccine Current treatments for Alzheimer’s do not stop disease progression, so the search for effective alternatives is ongoing. Some researchers hope that targeting amyloid buildup might make it possible to stop Alzheimer’s in its tracks. Many scientists are on the hunt for a vaccine, including Dr. […]
(HealthDay News) — Mild memory issues are common from time to time, especially as you age, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency says anything that affects the processes of thinking and learning can affect memory. It mentions these common causes of memory loss: Certain drugs can interfere with memory, including over-the-counter and prescription sleeping pills, antihistamines, anti-anxiety medications, antidepressants, schizophrenia medications and pain medicines. Heavy alcohol use can cause a deficiency in vitamin B1, which can affect memory. Stress, particularly because of emotional trauma, can trigger memory loss. Depression may trigger a lack of attention and focus that can affect memory. A blow to the head can trigger memory loss. People with HIV, tuberculosis, syphilis, herpes and other infections affecting the brain may have memory problems. An underactive or overactive thyroid can impact memory. Lack of quality sleep can affect memory. Deficiencies of vitamins B1 or B12 can affect memory. Copyright © 2018 HealthDay. All rights reserved.
What is donepezil, and how does it work (mechanism of action)? Donepezil is an oral medication used to treat Alzheimer’s disease. It belongs to a class of drugs called cholinesterase inhibitors that also includes tacrine (Cognex). Scientists believe that Alzheimer’s disease may result from a deficiency in chemicals (neurotransmitters) used by nerves in the brain to communicate with one another. Donepezil inhibits acetylcholinesterase, an enzyme responsible for the destruction of one neurotransmitter, acetylcholine. This leads to increased concentrations of acetylcholine in the brain, and the increased concentrations are believed to be responsible for the improvement seen during treatment with donepezil. Donepezil improves the symptoms but does not slow the progression of Alzheimer’s disease. Donepezil was approved by the FDA in 1996. What brand names are available for donepezil? Aricept, Aricept ODT Is donepezil available as a generic drug? Yes Do I need a prescription for donepezil? Yes What are the uses for donepezil? Donepezil is used for the treatment of mild, moderate, or severe dementia associated with Alzheimer’s disease. What are the side effects of donepezil? The most common side effects associated with donepezil are: headache, generalized pain, fatigue, dizziness, nausea, vomiting, diarrhea, loss of appetite, weight loss, muscle cramping, […]
By the time that the symptoms of dementia emerge in Alzheimer’s disease, tissue damage is well underway in the brain. Now, scientists propose that specific psychiatric symptoms – such as depression, anxiety, sleep disruption, and loss of appetite – may serve as markers of very early brain changes in Alzheimer’s. Depression and anxiety may be signs of early-stage Alzheimer’s. Working with the Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, investigators at the University of California in San Francisco (UCSF) studied results of postmortem brain tissue tests and compared them with psychiatric symptoms obtained from detailed interviews conducted with people who knew the deceased well, such as relatives and carers. They suggest that their study — a paper on which now features in the Journal of Alzheimer’s Disease — reveals that psychiatric symptoms are not the cause of Alzheimer’s, but more likely early indicators of the disease. Such markers could help doctors to diagnose Alzheimer’s disease much earlier and thus increase opportunities for slowing its progress, they note. Better understanding of Alzheimer’s The authors also propose that the findings could alter our understanding of how the biology of Alzheimer’s leads to psychiatric symptoms in people who […]
After studying the process in mice and flies, scientists suggest that failure to transport the molecular machines that break down proteins in cells could lie at the heart of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Share on PinterestFaulty transportation mechanisms within nerve cells may lead to neurodegeneration in Alzheimer’s or Parkinson’s disease. The ability to take apart proteins that are damaged, the wrong shape, or surplus to requirements is a crucial function in living cells. This process occurs at specific locations within the cell. Some of these locations can be more than 1 meter from the cell body in neurons, or nerve cells because they lie along their axons, which are long thin fibers that link them to other neurons. Cells use complex molecular machines called proteasomes to break down proteins at their specific sites of activity. One of the hallmarks of neurodegenerative disease is the buildup of proteins that have failed to break down. Examples include the accumulation of beta-amyloid in Alzheimer’s and alpha-synuclein in Parkinson’s disease. As undegraded proteins accumulate, they stick to each other and other substances, clogging up brain cells and disrupting their function. The cells eventually stop working and die. Transport failure The new […]
Scientists have found an inflammation mechanism that appears to play a key role in the formation of the toxic tau proteins that characterize Alzheimer’s and other brain diseases. Share on PinterestNew research finds that inflammation is responsible for the tau protein damage in Alzheimer’s disease. Alzheimer’s disease is the most common cause of dementia in older adults. Other forms include vascular, Lewy body, and frontotemporal dementia (FTD). Estimates from the National Institute of Aging, which is one of the National Institutes of Health (NIH), suggest that more than 5.5 million people in the United States have dementia due to Alzheimer’s disease. The newly discovered mechanism involves a protein complex called the NLRP3 inflammasome. Previous research had already identified the large molecule’s vital role in triggering inflammatory substances from its location within immune cells in the brain. In the new study, researchers from the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, both in Germany, led an international team’s investigation of the NLRP3 inflammasome in Alzheimer’s disease and FTD. They tested postmortem brain samples from people with and without FTD. They also used cultured brain cells and mice with characteristic brain features of Alzheimer’s and FTD. The lead […]
Memory can deteriorate naturally, due to age, and even when this process is not related to neurodegenerative conditions, such as Alzheimer’s, it can still affect a person’s quality of life. Now, researchers from Boston University in Massachusetts are exploring ways of fighting age-related memory decline. By resynchronizing brain waves, we could reverse some age-related memory problems. “Working memory […] is a fundamental building block of human cognition,” explains Robert Reinhart, Ph.D., the director of the university’s Visual Cognitive Neuroscience Laboratory. “It’s been called, classically, the ‘workbench of the mind’ or the ‘sketchpad of the mind.’ It allows us to hold information in our minds over a period of seconds,” he continues. Essentially, this is the type of memory that allows a person to make spontaneous calculations and assessments, and navigate daily life situations. But working memory also starts to naturally decline with age, which means that, as a person grows older, they may find it more difficult to perform some tasks, such as keeping track of their finances. “Working memory […] is where we think, where we problem-solve, where we reason, plan, perform mathematical calculations, make decisions. It’s essentially where consciousness lives.” Robert Reinhart, Ph.D. For this reason, Reinhart and […]
Latest Alzheimer’s News MONDAY, Nov. 26, 2018 (HealthDay News) — An experimental Alzheimer’s disease vaccine shows promise in animal tests, and researchers say it could have the potential to reduce dementia cases by half. In mice created to develop Alzheimer’s, the vaccine triggered an immune response that reduced accumulation of two toxic proteins associated with the fatal brain disease. There was a 40 percent reduction in beta-amyloid proteins and up to a 50 percent reduction in tau proteins, with no harmful side effects, according to researchers at the University of Texas. But there’s a catch: While such tests showed positive results in mice, research on animals doesn’t always produce the same effects in humans. More study is needed. Still, the researchers remained optimistic. Reductions in these proteins could someday have significant benefits in people at risk for Alzheimer’s disease, said study senior author Doris Lambracht-Washington, of the UT Southwestern Medical Center Brain Institute in Dallas. “If the onset of the disease could be delayed by even five years, that would be enormous for the patients and their families,” she said in a center news release. “The number of dementia cases could drop by half.” Lead researcher Dr. Roger Rosenberg is […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News TUESDAY, March 12, 2019 (HealthDay News) — Dementia appears to strike people of different races in different ways, brain autopsies have revealed. Hispanic and black people are more likely to suffer from dementia that’s caused in part by micro-strokes or hardening of the arteries that serve the brain, researchers report. On the other hand, whites are more likely to have dementia caused by “pure” Alzheimer’s disease, in which abnormalities like protein plaques and tangles damage the ability of brain cells to communicate with each other, said study co-author Brittany Dugger. She’s an assistant professor with the University of California, Davis, Alzheimer’s Disease Center. “We found that Hispanics and African-Americans are more likely to have mixed pathologies, a combination of Alzheimer’s disease and cerebrovascular disease,” Dugger noted. Minority groups in the United States are overall more likely to develop dementia, said Keith Fargo, director of scientific programs and outreach for the Alzheimer’s Association. Best estimates hold that blacks are about twice as likely as whites to suffer from dementia, and Hispanics are one and a half times more likely, Fargo said. This study provides fresh hope for preventing dementia in those groups, potentially narrowing […]
Latest Alzheimer’s News WEDNESDAY, Jan. 30, 2019 (HealthDay News) — The polar vortex that has enveloped much of the United States this week poses a special danger to people with Alzheimer’s disease and other types of dementia. “This type of weather can be hazardous for everyone, but even more so for individuals living with Alzheimer’s disease, who may have difficulty noticing temperature and weather changes or knowing who to call for help,” said Charles Fuschillo Jr., CEO and president of the Alzheimer’s Foundation of America. “A few easy steps can go a long way to help family caregivers keep their loved one with Alzheimer’s disease safe,” he added in a foundation news release. It’s important for family members and caregivers to know the signs of hypothermia. Be alert for shivering, exhaustion, sleepiness, slurred speech, memory loss and clumsy motor skills, the foundation advised. Caution is needed when using electric space heaters. They can pose a fire risk, especially when used with extension cords or if they get knocked over. For Alzheimer’s or dementia patients, use space heaters that automatically turn off when they reach a set temperature or tip over, the foundation said. Don’t use electric blankets to keep people […]
By Steven ReinbergHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, July 17, 2019 (HealthDay News) — One of the hallmarks of Alzheimer’s is the accumulation of beta-amyloid plaques in the brain, but what part those plaques play in the development of the disease isn’t clear. Now researchers have taken the first steps to trace the progression of plaque buildup in living patients. This way of “staging” the disease has implications for research and one day may help doctors treat this debilitating, fatal disease. “It is possible to stage individuals in terms of how advanced their beta-amyloid deposition is, using PET scans,” said lead researcher Dr. Niklas Mattsson, an associate professor of clinical neuroscience at Lund University in Sweden. When beta-amyloid appears, it follows certain stages, he explained. Some brain regions are involved early, others at the intermediate stage, and some in the late stage of Alzheimer’s. “These stages are also associated with other hallmarks of Alzheimer’s disease, such as levels of tau [another type of protein] in cerebral spinal fluid, cognitive decline and the wasting away of brain cells,” Mattsson added. “This staging system can be used both to improve research and perhaps also in clinical trials, to see if certain drugs […]
By E.J. MundellHealthDay Reporter Latest Alzheimer’s News MONDAY, July 15, 2019 (HealthDay News) — Even if you are unlucky enough to carry genes that predispose you to Alzheimer’s disease, a healthy lifestyle can minimize that risk, new research shows. The study tracked the genetics, lifestyles and Alzheimer’s disease incidence of nearly 200,000 British people over 60 for an average of eight years. Researchers found that people who had a high genetic risk for Alzheimer’s and who followed unhealthy lifestyles had nearly triple the odds of getting the disease, compared to people with low genetic risk and a healthy lifestyle. Conversely, living well — exercising regularly, eating a balanced diet, not smoking, and drinking moderately — appeared to cut the odds for Alzheimer’s, even among those at high genetic risk. Among people found to be at highest genetic risk, healthy living appeared to reduce the chances of developing the disease by 35%, said a team led by David Llewellyn at the University of Exeter Medical School in England. That implies that “1 case of dementia would be prevented for each 121 individuals per [every] 10 years with high genetic risk who improved their lifestyle from unfavorable to favorable,” the researchers reported […]
Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer’s disease. Currently, there is no way to halt its progress, but clinical trials of new drugs are underway. What approach will serve specialists best? A new review of clinical trials advises on the best way forward. According to the World Health Organization (WHO), approximately 50 million people around the world live with dementia, and approximately 60–70 percent have Alzheimer’s disease. The greatest risk factor for Alzheimer’s disease is aging, and people ages 65 or older are the most vulnerable. Current treatments for this condition address its symptoms, such as memory loss and behavioral changes. However, more and more research aims to find a therapy that will tackle the biological changes that characterize Alzheimer’s disease. But are researchers on the right track with their investigations, and what would be the best treatment approach? A new comprehensive review published in the journal Neurology, and available online, addresses these questions. Most trials target brain pathologies In the review, specialists from the Alzheimer’s Drug Discovery Foundation in New York, NY analyze current clinical trials for dementia drugs and advise about the best approach going forward. “Alzheimer’s is […]
Latest Alzheimer’s News WEDNESDAY, Oct. 30, 2019 (HealthDay News) — Nearly 13 million Americans will have dementia by 2040 — nearly twice as many as today, a new report says. The number of women with dementia is expected to rise from 4.7 million next year to 8.5 million in 2040. The number of men with dementia is projected to increase from 2.6 million to 4.5 million. Over the next 20 years, the economic impact of Alzheimer’s disease and other forms of dementia will be more than $2 trillion. Women will shoulder more than 80% of those costs, according to a report released Tuesday at the 2019 Milken Institute Future of Health Summit, in Washington, D.C. “Longer life spans are perhaps one of the greatest success stories of our modern public health system,” said lead author Nora Super, senior director of the Milken Institute Center for the Future of Aging. “But along with this success comes one of our greatest challenges,” she added in an institute news release. “Our risk of developing dementia doubles every five years after we turn 65; by age 85, nearly one in three of us will have the disease.” With no cure on the horizon, reducing […]
Latest Alzheimer’s News FRIDAY, Jan. 18, 2019 (HealthDay News) — Frailty is associated with a higher risk of both Alzheimer’s disease and its crippling symptoms, a new study shows. “By reducing an individual’s physiological reserve, frailty could trigger the clinical expression of dementia when it might remain asymptomatic in someone who is not frail,” said study leader Dr. Kenneth Rockwood, a professor at Dalhousie University in Halifax, Canada. “This indicates that a ‘frail brain’ might be more susceptible to neurological problems like dementia as it is less able to cope with the pathological burden,” he added. The study included 456 adults in Illinois, aged 59 and older, who did not have Alzheimer’s when first enrolled in the Rush Memory and Aging Project. They underwent annual assessments of their mental and physical health, and their brains were examined after they died. By their last assessment, 53 percent of the participants had been diagnosed with possible or probable Alzheimer’s disease. For the physical assessments, the researchers created a frailty index using 41 components, including fatigue, joint and heart problems, osteoporosis, mobility and meal preparation abilities. Overall, 8 percent of the participants had significant Alzheimer’s disease-related brain changes without having been diagnosed with […]
What is galantamine, and how does it work (mechanism of action)? Galantamine is in a class of drugs called cholinesterase inhibitors that also includes tacrine (Cognex), donezepil (Aricept), and rivastigmine (Exelon). Cholinesterase inhibitors inhibit (block) the action of acetylcholinesterase, the enzyme responsible for the destruction of acetylcholine. Acetylcholine is one of several neurotransmitters in the brain, chemicals that nerve cells use to communicate with one another. Reduced levels of acetylcholine in the brain are believed to be responsible for some of the symptoms of Alzheimer’s disease. By blocking the enzyme that destroys acetylcholine, galantamine increases the concentration of acetylcholine in the brain, and this increase is believed to be responsible for the improvement in thinking. Galantamine was approved by the FDA in 2001. (The brand name of galantamine was changed in 2005 from Reminyl to Razadyne.) What brand names are available for galantamine? Razadyne, Razadyne ER Is galantamine available as a generic drug? GENERIC AVAILABLE: No Do I need a prescription for galantamine? Yes What are the uses for galantamine? Galantamine is an oral medication used to treat patients with Alzheimer’s disease, a form of dementia. What are the side effects of galantamine? The most frequent side effects seen with […]
Researchers found that using a computer, playing games, and participating in social activities may reduce the risk of mild cognitive impairment. New research suggests that playing games, using a computer, and having a rich social life can keep mild cognitive impairment at bay. Our brains go through changes as we get older, and some people may experience issues with memory, thinking, or judgment. Mild cognitive impairment (MCI) is the stage between age-related cognitive decline and dementia — however, MCI does not significantly affect daily life and activities. People with MCI tend to forget things, lose their train of thought or the thread of conversations, and feel overwhelmed by making decisions. According to the Centers for Disease Control and Prevention (CDC), more than 16 million people in the United States are living with cognitive impairment. MCI may increase the risk of dementia, but not everyone with MCI goes on to develop the condition. To date, the Food and Drug Administration (FDA) have not approved any treatments specifically for MCI. Lifestyle choices such as physical exercise and intellectual stimulation have positive effects on the brain. In recent years, researchers have been conducting more studies to find treatments that may prevent cognitive decline. […]
By Amy NortonHealthDay Reporter Latest Alzheimer’s News MONDAY, Aug. 26, 2019 (HealthDay News) — Seniors, here’s a recipe for preventing dementia: eat well, exercise and don’t smoke. The only catch, according to a new study? If you carry genes that leave you vulnerable to the memory-robbing disease, lifestyle might not be enough. In the study, researchers found that of over 6,300 adults aged 55 and older, those with healthy habits had a lower risk of being diagnosed with dementia over the next 15 years. That was true, at least, for people at low or intermediate risk of dementia because of their genes. Among people who carried high-risk genes, there was no evidence that lifestyle swayed the odds of developing dementia. The findings, published Aug. 26 in the journal Nature Medicine, support a number of past studies suggesting that heart-healthy habits may also protect the brain. But they are at odds with some past research, too: Other studies have suggested that lifestyle choices do, in fact, make a difference for people at high genetic risk for dementia. The reasons for the differing findings are unclear. But the age of the study participants could be a factor, according to lead researcher Dr. […]
By Alan MozesHealthDay Reporter Latest Alzheimer’s News WEDNESDAY, Nov. 13, 2019 (HealthDay News) — Could illiteracy up your odds for dementia? That’s the suggestion of a study that found seniors who couldn’t read or write were two to three times more likely to develop dementia than those who could. The finding “provides strong evidence for a link between illiteracy and dementia risk,” said study author Jennifer Manly, a professor of neuropsychology at Columbia University’s College of Physicians and Surgeons in New York City. The finding also offers sobering insight into how dementia risk could be disproportionately affecting the roughly 32 million illiterate adults in the United States. For the study, Manly and her colleagues focused on men and women who were at least 65, with an average age of 77. Most had been born and raised in rural areas of the Dominican Republic before moving to northern Manhattan. None — including those who could read or write — had gone to school for more than four years. Three separate groups of participants were tracked for an average of about four years, with the first group formed in 1992, followed by a second in 1999 and a third in 2009, for […]
You have chosen to share the following article: How elderberries can help you fight the flu To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.Note: Please don’t include any URLs in your comments, as they will be removed upon submission. We do not store details you enter into this form. Please see our privacy policy for more information. Message sent successfully The details of this article have been emailed on your behalf. Click here to return to the Medical News Today home page.
New research in mice reveals the mechanisms through which two experimental drugs that may treat Alzheimer’s disease have broader, anti-aging properties and can reverse age-related cognitive decline. Share on PinterestNew research explains how two experimental dementia drugs may reverse normal aging. Family history, genes, and some lifestyle choices all influence a person’s risk of Alzheimer’s disease, but age is the greatest risk factor that researchers are aware of. Most people who receive a diagnosis of Alzheimer’s are at least 65 years old. In fact, after that age, the risk of developing the condition doubles every 5 years. However, scientists do not yet fully understand, on a molecular level, how aging is involved in driving Alzheimer’s. Previous research has shown that faulty glucose metabolism in the brain occurs before the onset of Alzheimer’s symptoms. Cerebral glucose metabolism declines with age anyway, but in Alzheimer’s, the decline is much more severe. Furthermore, other studies have shown that dysfunctional mitochondria in the brain’s cells are a hallmark of both normal aging and Alzheimer’s. Armed with this knowledge, researchers from the Salk Institute for Biological Studies and the Scripps Research Institute — both in La Jolla, CA — set out to test several drugs […]
It is still unclear exactly what causes Alzheimer’s disease, which is a neurodegenerative condition chiefly characterized by memory loss and other forms of cognitive impairment. However, new research is uncovering more of the factors that contribute to its pathology. According to a new study, a blood protein leaked into the brain contributes to cognitive decline. According to existing guidelines, the main mechanism associated with cognitive problems in the brains of people with Alzheimer’s disease is the formation of beta-amyloid plaques. These are buildups of toxic proteins that disrupt the normal functioning of synapses. Synapses are the connections formed between brain cells that allow information to circulate within and to and from the brain. However, in a new study from the Gladstone Institutes in San Francisco, CA, a team of researchers has identified another mechanism that affects how synapses work, contributing to Alzheimer’s pathology. The researchers began by investigating problems that appear in the blood vessel network in the brain, which is another biological characteristic of this form of dementia. Senior investigator Prof. Katerina Akassoglou and her team have for the first time identified a blood-derived protein that leaks into the brain disrupting cell-to-cell communication. The findings, which appear in the […]
By Dennis ThompsonHealthDay Reporter Latest Alzheimer’s News THURSDAY, Feb. 28, 2019 (HealthDay News) — The old saying, “TV rots your brain,” could have some validity for folks as they age. In a new study, middle-aged people who watched television for more than 3.5 hours a day experienced a decline in their ability to remember words and language over the next six years, British researchers found. What’s worse, it appears that the more TV you watch, the more your verbal memory will deteriorate, researchers said. “Overall, our results suggests that adults over the age of 50 should try and ensure television viewing is balanced with other contrasting activities,” said lead researcher Daisy Fancourt. She’s a senior research fellow at University College London. For the study, researchers relied on data from a long-term study of aging involving more than 3,600 residents of England. Participants reported the amount of hours of TV they watched daily. They also had their thinking and reasoning skills regularly tested as part of the study. People who watched less than 3.5 hours of TV a day didn’t seem to suffer any deterioration in their brain power, Fancourt said. But more than that amount, people became increasingly apt to […]
(HealthDay News) — If you are caring for a loved one who has Alzheimer’s disease, you may develop feelings of grief as the person starts to change, the Alzheimer’s Foundation says. Latest Alzheimer’s News There are five phases of grieving: denial, anger, guilt, sadness and acceptance. The association suggests how to cope with grief and loss: Face your feelings and accept them. Prepare to have feelings of loss as dementia progresses. Understand that no two people grieve in exactly the same way. Talk with someone you trust about your feelings. Stay involved in activities that you enjoy. Join a support group. Accept things that you cannot change. Take care of yourself. Copyright © 2018 HealthDay. All rights reserved. CONTINUE SCROLLING FOR NEXT NEWS ARTICLE
A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat or cure Alzheimer’s disease and other serious conditions, the U.S. Food and Drug Administration says. Latest Alzheimer’s News The agency said it posted 12 warning letters and five online advisory letters to U.S. and foreign companies illegally selling more than 58 products, many of which are marketed as dietary supplements. The products — which include tablets, capsules and oils and are often sold on websites and social media — have not been reviewed by the FDA and may be ineffective, unsafe and could prevent a person from seeking an appropriate diagnosis and treatment, according to the FDA The companies have 15 days to respond to the FDA and outline how they intend to correct the violations. Product seizures and/or injunctions are among the actions the FDA could take if the violations are not corrected. “Science and evidence are the cornerstone of the FDA’s review process and are imperative to demonstrating medical benefit, especially when a product is marketed to treat serious and complex diseases like Alzheimer’s,” FDA Commissioner Dr. Scott Gottlieb said in an agency news release. “Alzheimer’s is a […]
A prescription drug already in use for the treatment of high blood pressure could be effective against conditions such as Parkinson’s, Alzheimer’s, and Huntington’s, in which toxic proteins build up in brain cells. Scientists could repurpose felodipine to prevent Parkinson’s disease. Scientists at the University of Cambridge in the United Kingdom and the Guangzhou Institutes of Biomedicine and Health in China suggest that the hypertension drug felodipine could be a promising candidate for “repurposing” as a treatment for neurodegenerative conditions. In experiments with zebrafish and mice, they showed that felodipine can prompt a cellular recycling process called autophagy to clear away toxic proteins in brain cells, or neurons. “Our data suggest,” they write in a recent Nature Communications paper, “that felodipine induces autophagy in neurons and enhances removal of a range of disease-causing proteins: mutant huntingtin, mutant [alpha]-synuclein, and tau.” Mutant huntingtin is characteristic of Huntington’s disease, while mutant alpha-synuclein and tau are hallmarks of Parkinson’s disease and Alzheimer’s disease, respectively. The study is important because it shows that felodipine can remove mutant alpha-synuclein from the brains of mice at blood levels “similar to those that would be seen in humans taking the drug [for hypertension].” “This is the first […]
For years, many experts have assumed that spending more time in education protects against dementia. The latest study may overturn this long-held theory. A new study examines the links between education and dementia risk over time. It will have escaped no one’s attention that dementia is on the rise. The most common type of dementia is Alzheimer’s. According to the Alzheimer’s Association, an estimated 5.7 million adults in the United States have Alzheimer’s. Primarily due to our increasing lifespan, dementia incidence is set to keep rising. Currently, there is no cure, and treatments can only reduce certain symptoms. For this reason, it is vital that we understand the relevant risk factors and discover ways to prevent or slow down dementia. Some risk factors are well-known, such as smoking and lack of physical activity. Well-known protective factors include sticking to a healthful diet. Education and cognitive reserve Many experts think that the length of time someone spends in education helps protect against dementia. Although studies have generated conflicting or inconclusive results, many researchers believe that higher levels of educational attainment provide an individual with a certain “cognitive reserve.” Scientists believe that this hypothetical reserve lowers the risk or, at the very […]
A global study on attitudes toward dementia has shown that two-thirds of people believe it to be a natural risk of getting older, which could be limiting the help that people seek. The vast majority of people believe that they will develop dementia and that they can do little about it, new research finds. Every 3 seconds, someone develops dementia somewhere in the world. In the United States alone, 5.8 million people are living with Alzheimer’s, and every 65 seconds, another person develops the disease. Alzheimer’s is the sixth leading cause of death in the U.S., beating breast and prostate cancer together, and it is one of the world’s fastest growing causes of death. According to Alzheimer’s Disease International (ADI), the number of people living with dementia is likely to triple from the current 50 million to 152 million by 2050. Despite the prevalence of this neurodegenerative disorder, the world’s largest survey of attitudes toward it has shown that there is very little true understanding across the globe, even among healthcare professionals. The study, which surveyed 70,000 people in 155 countries, found that 62% of healthcare professionals also believe that dementia is a normal part of aging. The findings also […]
A large study concludes that atrial fibrillation does, indeed, raise the risk of dementia even in people who did not have a stroke and that anticoagulants may reduce this risk. An irregular heartbeat may be a sign of A-fib, which may, in turn, raise dementia risk. Atrial fibrillation (A-fib) is a condition in which the heart beats irregularly. More specifically, the atria of the heart — the chambers that receive blood and pump it out to the heart’s ventricles and the rest of the body — beat at an irregular rhythm. A-fib is the most common form of arrhythmia, affecting between 2.7 and 6.1 million adults in the United States. Previous research has shown that people with A-fib have a higher risk of dementia, and also that people can take blood thinners to reduce this risk. New research confirms that the above is true, even in people who never experienced a stroke. The new study is the largest of its kind ever conducted. Boyoung Joung, who is a professor of cardiology and internal medicine at Yonsei University College of Medicine in Seoul, Republic of Korea, is the leading author of the paper, which appears in the European Heart Journal. A-fib […]
PET scans that can detect changes in the brain relating to Alzheimer’s disease could improve the diagnosis and medical care of people with dementia and similar symptoms. An innovative type of brain scan may improve care for people with Alzheimer’s disease, dementia, and other forms of cognitive impairment. Investigators came to this conclusion after analyzing the early results of a study that is examining the clinical impact of a new type of scan called amyloid PET imaging. The study is a nationwide trial involving more than 11,000 people with mild cognitive impairment (MCI) or dementia symptoms who enrolled at 595 sites across the United States. It is the first investigation of its kind, and all the participants are beneficiaries of Medicare, the U.S. federal health insurance plan. The results of the first phase of the trial, which now feature in a JAMA paper, reveal that providing doctors with amyloid PET scan results can affect the medical management of people with dementia symptoms. In almost two-thirds of cases, doctors changed their minds about medications, counseling, and other medical decisions after seeing the amyloid PET imaging results. Also, in more than a third of cases, doctors altered their diagnosis of the cause […]
An Alzheimer’s diagnosis often relies on signs of memory problems. However, these issues usually do not appear until years after the disease has taken hold. A new smartphone game is using spatial navigation to detect Alzheimer’s before it is too late. A simple game that people can play on their smartphones could help detect Alzheimer’s risk. Another person develops Alzheimer’s disease every 3 seconds, according to Alzheimer’s Disease International. The number of people living with this most common form of dementia currently stands at around 50 million. By 2050, experts expect this figure to have tripled. The last “significant breakthrough” in Alzheimer’s research happened 4 decades ago, states the latest World Alzheimer’s Report. However, a recently developed smartphone game may alter that statistic. “Research shows us that the brain changes associated with diseases like Alzheimer’s begin decades before symptoms like memory loss start,” says Hilary Evans, chief executive at Alzheimer’s Research United Kingdom. “[F]or future Alzheimer’s treatments to be effective, it’s likely they must be given at the earliest stages of disease, before there’s too much damage to the brain.” Navigating space A collaboration between the organization, the University of East Anglia (UEA) and University College London in the U.K., […]
Latest Alzheimer’s News THURSDAY, Feb. 6, 2020 (HealthDay News) — A breakthrough study has identified a class of natural gene variants that may protect against Alzheimer’s disease. For the study, researchers at University College London analyzed DNA from more than 10,000 people — half with Alzheimer’s and half without. The investigators found that these gene variants reduce the functioning of proteins called tyrosine phosphatases. These proteins impair the activity of a cell signaling pathway important for cell survival, explained the authors of the study published online Feb. 5 in the Annals of Human Genetics. The pathway could be a key target for drugs to treat Alzheimer’s, and the study authors said that the findings provide more evidence that other genes may be linked to one’s risk for the memory disorder. “These results are quite encouraging. It looks as though when naturally occurring genetic variants reduce the activity of tyrosine phosphatases, then this makes Alzheimer’s disease less likely to develop, suggesting that drugs which have the same effect might also be protective,” lead author David Curtis said in a college news release. He’s a professor of genetics, evolution and environment. Previous research in mice and rats suggested that inhibiting the function […]
close
The information contained within this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Members contribute personal experiences by sharing what did or didn’t work to address their concern and help educate others which may expedite recovery. As such, always seek the advice of your physician or other qualified health provider with any questions about your medical condition. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
Recent Comments